Latest & greatest articles for mammography

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on mammography or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on mammography and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for mammography

1. Magnetic Resonance Imaging as an Adjunct to Mammography for Breast Cancer Screening in Women at Less Than High Risk for Breast Cancer

Magnetic Resonance Imaging as an Adjunct to Mammography for Breast Cancer Screening in Women at Less Than High Risk for Breast Cancer Magnetic Resonance Imaging as an Adjunct to Mammography for Breast Cancer Screening in Women at Less Than High Risk for Breast Cancer - Health Quality Ontario (HQO) Let's make our health system healthier Open Menu Quick Links Search Search A A A Evidence to Improve Care Share: Magnetic Resonance Imaging as an Adjunct to Mammography for Breast Cancer Screening (...) in Women at Less Than High Risk for Breast Cancer Ontario Health Technology Advisory Committee Recommendation The Ontario Health Technology Advisory Committee recommends against publicly funding screening breast magnetic resonance imaging (MRI) as an adjunct to screening mammography for women who are at less than high risk for breast cancer and who have no personal history of breast cancer Breast cancer is the most common cancer among Canadian women. The most common form of screening for breast cancer

2017 Health Quality Ontario

2. Choosing Wisely Canada recommendation - Don’t routinely do screening mammography for average risk women aged 40 – 49. Individual assessment of each woman’s preferences and risk should guide the discussion and decision regarding mammography screening in th

Choosing Wisely Canada recommendation - Don’t routinely do screening mammography for average risk women aged 40 – 49. Individual assessment of each woman’s preferences and risk should guide the discussion and decision regarding mammography screening in th Don’t do imaging for lower-back pain unless red flags are present. Red flags include, but are not limited to, severe or progressive neurological deficits or when serious underlying conditions such as osteomyelitis are suspected. Imaging (...) Vitamin D levels in patients with significant renal or metabolic disease. 1 2 3 Family Medicine Thirteen Things Physicians and Patients Should Question by College of Family Physicians of Canada Last updated: January 2018 4 5 6Don’t routinely do screening mammography for average risk women aged 40 – 49. Individual assessment of each woman’s preferences and risk should guide the discussion and decision regarding mammography screening in this age group. If, after this careful assessment and discussion

2019 CPG Infobase

4. Screening mammography program: physician protocol for screening mammograms

Screening mammography program: physician protocol for screening mammograms Screening Mammography Program Physician Protocol for Screening Mammograms risk policy rationale Average risk Ages 40-49 Health care providers are encouraged to discuss the benefits and limitations of screening mammography with asymptomatic women in this age group. If screening mammography is chosen, it is available every two years. Patients will be recalled every two years. A health care provider’s referral (...) in women ages 50 and older who have no risk factors other than being an aging female. Average risk Ages 75+ Health care providers are encouraged to discuss the benefits and limitations of screening mammography with asymptomatic women in this age group. Health care providers should discuss stopping screening when there are comorbidities associated with a limited life expectancy or physical limitations for mammography that prevent proper positioning. If screening mammography is chosen, it is available

2014 CPG Infobase

5. Magnetic resonance imaging as an adjunct to mammography for breast cancer screening in women atless than high risk for breast cancer: a health technology assessment

Magnetic resonance imaging as an adjunct to mammography for breast cancer screening in women atless than high risk for breast cancer: a health technology assessment Magnetic resonance imaging as an adjunct to mammography for breast cancer screening in women at less than high risk for breast cancer: a health technology assessment Magnetic resonance imaging as an adjunct to mammography for breast cancer screening in women at less than high risk for breast cancer: a health technology assessment (...) Health Quality Ontario Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Health Quality Ontario. Magnetic resonance imaging as an adjunct to mammography for breast cancer screening in women at less than high risk for breast cancer: a health technology assessment. Toronto: Health Quality Ontario (HQO). Ontario health technology assessment series

2017 Health Technology Assessment (HTA) Database.

6. Ultrasound as an Adjunct to Mammography for Breast Cancer Screening

Ultrasound as an Adjunct to Mammography for Breast Cancer Screening Health Quality Ontario The provincial advisor on the quality of health care in Ontario Let’s make our health system healthier Ultrasound as an Adjunct to Mammography for Breast Cancer Screening: OHTAC Recommendation ONTARIO HEALTH TECHNOLOGY ADVISORY COMMITTEE RECOMMENDATIONS ? The Ontario Health Technology Advisory Committee recommends publicly funding screening breast ultrasound as an adjunct to screening mammography for high (...) -risk women in whom magnetic resonance imaging (MRI) is contraindicated. ? The Ontario Health Technology Advisory Committee recommends against publicly funding screening breast ultrasound as an adjunct to screening mammography in women at average risk for breast cancer. RATIONALE FOR THE RECOMMENDATION DECISION Given the absence of evidence demonstrating benefit, 1 there was consensus among members of the Ontario Health Technology Advisory Committee (OHTAC) that adjunct screening breast ultrasound

2016 Health Quality Ontario

7. Two-view digital breast tomosynthesis versus digital mammography in a population-based breast cancer screening programme (To-Be): a randomised, controlled trial Full Text available with Trip Pro

Two-view digital breast tomosynthesis versus digital mammography in a population-based breast cancer screening programme (To-Be): a randomised, controlled trial Digital breast tomosynthesis is an advancement of mammography, and has the potential to overcome limitations of standard digital mammography. This study aimed to compare first-generation digital breast tomo-synthesis including two-dimensional (2D) synthetic mammograms versus digital mammography in a population-based screening (...) programme.BreastScreen Norway offers all women aged 50-69 years two-view (craniocaudal and mediolateral oblique) mammographic screening every 2 years and does independent double reading with consensus. We asked all 32 976 women who attended the programme in Bergen in 2016-17, to participate in this randomised, controlled trial with a parallel group design. A study-specific software was developed to allocate women to either digital breast tomosynthesis or digital mammography using a 1:1 simple randomisation method

2019 EvidenceUpdates

8. Management of Women With Dense Breasts Diagnosed by Mammography

Management of Women With Dense Breasts Diagnosed by Mammography Management of Women With Dense Breasts Diagnosed by Mammography - ACOG Menu ▼ Management of Women With Dense Breasts Diagnosed by Mammography Page Navigation ▼ A correction was published in January 2016 for this title. Click to view the correction. Number 625, March 2015 (Reaffirmed 2019) Committee on Gynecologic Practice This document reflects emerging clinical and scientific advances as of the date issued and is subject to change (...) . The information should not be construed as dictating an exclusive course of treatment or procedure to be followed. Management of Women With Dense Breasts Diagnosed by Mammography ABSTRACT: Women with dense breasts have a modestly increased risk of breast cancer and experience reduced sensitivity of mammography to detect breast cancer. However, evidence is lacking to advocate for additional testing until there are clinically validated data that indicate improved screening outcomes. Currently, screening

2015 American College of Obstetricians and Gynecologists

9. Concurrent versus Sequential Digital Mammography and MRI for Breast Cancer Screening in High-Risk Patients

Concurrent versus Sequential Digital Mammography and MRI for Breast Cancer Screening in High-Risk Patients Disclaimer: The Rapid Response Service is an information service for those involved in planning and providing health care in Canada. Rapid responses are based on a limited literature search and are not comprehensive, systematic reviews. The intent is to provide a list of sources of the best evidence on the topic that CADTH could identify using all reasonable efforts within the time allowed (...) Sequential Digital Mammography and MRI for Breast Cancer Screening in High-Risk Patients: Comparative Clinical Effectiveness, Cost- Effectiveness, and Guidelines DATE: 06 May 2015 RESEARCH QUESTIONS 1. What is the comparative clinical effectiveness of concurrent versus sequential digital mammography and magnetic resonance imaging (MRI) for breast cancer screening in high-risk patients? 2. What is the comparative cost-effectiveness of concurrent versus sequential digital mammography and MRI for breast

2015 Canadian Agency for Drugs and Technologies in Health - Rapid Review

10. Mammography

Mammography Top results for mammography - Trip Database or use your Google+ account Find evidence fast ALL of these words: Title only Anywhere in the document ANY of these words: Title only Anywhere in the document This EXACT phrase: Title only Anywhere in the document EXCLUDING words: Title only Anywhere in the document Timeframe: to: Combine searches by placing the search numbers in the top search box and pressing the search button. An example search might look like (#1 or #2) and (#3 or #4 (...) ) Loading history... Population: Intervention: Comparison: Outcome: Population: Intervention: Latest & greatest articles for mammography The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you

2018 Trip Latest and Greatest

11. Magnetic Resonance Imaging as an Adjunct to Mammography for Breast Cancer Screening in Women at Less Than High Risk for Breast Cancer

Magnetic Resonance Imaging as an Adjunct to Mammography for Breast Cancer Screening in Women at Less Than High Risk for Breast Cancer Health Technology Assessment - Health Quality Ontario (HQO) Let's make our health system healthier Open Menu Quick Links Search Search A A A Evidence to Improve Care Share: Health Technology Assessment To continuously improve the quality of health care in Ontario, we use established scientific methods to analyze evidence and develop assessments of new

2016 Health Quality Ontario

12. Magnetic resonance imaging as an adjunct to mammography for breast cancer screening in women at less than high risk for breast cancer: OHTAC recommendation

Magnetic resonance imaging as an adjunct to mammography for breast cancer screening in women at less than high risk for breast cancer: OHTAC recommendation Magnetic resonance imaging as an adjunct to mammography for breast cancer screening in women at less than high risk for breast cancer: OHTAC recommendation Magnetic resonance imaging as an adjunct to mammography for breast cancer screening in women at less than high risk for breast cancer: OHTAC recommendation Health Quality Ontario Record (...) Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Health Quality Ontario. Magnetic resonance imaging as an adjunct to mammography for breast cancer screening in women at less than high risk for breast cancer: OHTAC recommendation. Toronto: Health Quality Ontario (HQO). 2016 Authors' conclusions The Ontario Health Technology Advisory Committee (OHTAC

2017 Health Technology Assessment (HTA) Database.

13. Tomosynthesis (3D Mammography) for Breast Cancer Screening

Tomosynthesis (3D Mammography) for Breast Cancer Screening 1 Issue 135 ? May 2015 Issues in Emerging Health Technologies Summary ? Digital breast tomosynthesis (DBT) is a novel imaging technology that captures three- dimensional (3D) images of the breast. ? DBT can be used for screening or diagnosis. ? Seven recent, large screening studies that each enrolled more than 10,000 women showed that DBT can reduce the need to recall women for further testing compared with current two- dimensional (2D (...) Traditional two-dimensional (2D) mammography captures two static images of the breast. One particular shortcoming of 2D technology is the overlapping of breast images that can decrease accuracy of interpretation. With digital breast tomosynthesis (DBT), an X-ray beam sweeps in an arc of 15 to 50 degrees (depending on the manufacturer) across the breast, and an electronic detector digitally captures between nine and 25 X-ray projection images. 1-6 These images are generally captured in two views

2015 Canadian Agency for Drugs and Technologies in Health - Rapid Review

14. The TOMMY trial: a comparison of TOMosynthesis with digital MammographY in the UK NHS Breast Screening Programme - a multicentre retrospective reading study comparing the diagnostic performance of digital breast tomosynthesis and digital mammography with Full Text available with Trip Pro

The TOMMY trial: a comparison of TOMosynthesis with digital MammographY in the UK NHS Breast Screening Programme - a multicentre retrospective reading study comparing the diagnostic performance of digital breast tomosynthesis and digital mammography with TOMMY trial: A comparison of TOMosynthesis with digital MammographY in the UK NHS Breast Screening Programme Journals Library An error occurred retrieving content to display, please try again. >> >> >> Page Not Found Page not found (404) Sorry (...) Manchester, Manchester, UK 8 Department of Radiology, St Bartholomew’s Hospital, London, UK 9 National Co-ordinating Centre for Physics of Mammography, Royal Surrey County Hospital, Guildford, UK 10 Department of Imaging Science and Biomedical Engineering, University of Manchester, Manchester, UK 11 East Anglian Regional Radiation Protection Service, Cambridge University Hospitals, Cambridge, UK 12 Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, UK * Corresponding

2015 NIHR HTA programme

15. Overdiagnosis from mammography screening

Overdiagnosis from mammography screening Overdiagnosis from mammographic screening | Cancer Australia ") //--> ") //--> Search form Search You are here » » Revised & updated: 2014 , 2010 Published: 2008 This position statement has been endorsed by the Australian Health Ministers’ Advisory Council Standing Committee on Screening, Cancer Council Australia and the Royal Australian and New Zealand College of Radiologists, and is supported by the Cancer Australia Advisory Council. Context National (...) cancer risk factors between screened and unscreened women and what estimates are used when making these adjustments; the duration for which women are followed after screening cessation; the estimates used for lead-time effects (i.e., the time diagnosis was brought forward through screening); whether account is taken of non-diagnostic mammography outside the screening program and how this is done; death rates from other diseases and hence variations in life expectancy at time of screening; screening

2014 Cancer Australia

16. Ultrasound as an adjunct to mammography for breast cancer screening: a health technology assessment

Ultrasound as an adjunct to mammography for breast cancer screening: a health technology assessment Ultrasound as an adjunct to mammography for breast cancer screening: a health technology assessment Ultrasound as an adjunct to mammography for breast cancer screening: a health technology assessment Health Quality Ontario Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made (...) for the HTA database. Citation Health Quality Ontario. Ultrasound as an adjunct to mammography for breast cancer screening: a health technology assessment. Toronto: Health Quality Ontario (HQO). Ontario health technology assessment series; 16(15). 2016 Authors' conclusions We found no evidence that evaluated the comparative effectiveness or diagnostic accuracy of screening breast ultrasound as an adjunct to mammography among average-risk women aged 50 years and over. In women at high risk of developing

2016 Health Technology Assessment (HTA) Database.

17. A study of overdiagnosis due to mammography reported during Breast Cancer Awareness Month

A study of overdiagnosis due to mammography reported during Breast Cancer Awareness Month A study of overdiagnosis due to mammography reported during Breast Cancer Awareness Month | ScienceBlogs Advertisment Search Search Toggle navigation Main navigation A study of overdiagnosis due to mammography reported during Breast Cancer Awareness Month By on October 13, 2016. I knew it. I just knew it. I knew I couldn’t get through October, a.k.a. Breast Cancer Awareness Month, without a controversial (...) mammography study to sink my teeth into. And I didn’t. I suppose I should just be used to this now. I’m referring to the latest opus from H. Gilbert Welch and colleagues that appeared in the New England Journal of Medicine last night, . Yes, it’s about overdiagnosis, something I’ve blogged about more times than I can remember now, but it’s actually a rather interesting take on the issue. Before 2008 or so, I never gave that much thought to the utility of mammographic screening as a means of early

2016 Respectful Insolence

18. [Diagnostic performance of digital mammography in breast cancer screening]

[Diagnostic performance of digital mammography in breast cancer screening] Rendimiento diagnostico de la mamografia digital en el cribado del cancer de mama [Diagnostic performance of digital mammography in breast cancer screening] Rendimiento diagnostico de la mamografia digital en el cribado del cancer de mama [Diagnostic performance of digital mammography in breast cancer screening] Marquez Cruz MD, Marquez Calderon S Record Status This is a bibliographic record of a published health (...) technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Marquez Cruz MD, Marquez Calderon S. Rendimiento diagnostico de la mamografia digital en el cribado del cancer de mama. [Diagnostic performance of digital mammography in breast cancer screening] Seville: Andalusian Agency for Health Technology Assessment (AETSA). Informes de Evaluacion de Tecnologias Sanitarias AETSA 2007/09. 2009 Authors' conclusions No important

2009 Health Technology Assessment (HTA) Database.

19. Decision Aid for women aged 70 thinking about whether to continue or stop mammography screening for breast cancer

Decision Aid for women aged 70 thinking about whether to continue or stop mammography screening for breast cancer Research at Sydney School of Public Health - Faculty of Medicine and Health Type to search Search Courses All content Study Campus life About us Research Alumni & giving News & opinion Study medicine and health Clinical schools Schools Our research Industry and community News and events About Our research aims to improve health, wellbeing and fairness and boost healthcare outcomes

2017 University of Sydney Decision Aids

20. Mammography Full Text available with Trip Pro

Mammography Mammography - Wikipedia Mammography From Wikipedia, the free encyclopedia Mammography Mammography BH0 [ ] Mammography (also called mastography ) is the process of using low-energy (usually around 30 ) to examine the human for diagnosis and screening. The goal of mammography is the early detection of , typically through detection of characteristic masses or . As with all X-rays, mammograms use doses of to create images. These images are then analyzed for abnormal findings (...) . It is usual to employ lower-energy X-rays, typically Mo (K-shell x-ray energies of 17.5 and 19.6 keV) and Rh (20.2 and 22.7 keV) than those used for of . , ductography, (PEM), and (MRI) are adjuncts to mammography. Ultrasound is typically used for further evaluation of masses found on mammography or palpable masses not seen on mammograms. Ductograms are still used in some institutions for evaluation of bloody nipple discharge when the mammogram is non-diagnostic. MRI can be useful for further evaluation

2012 Wikipedia